Maurizio Bottiroli

TL;DR: From a functional viewpoint, patients with FM have a more severely impaired LVEF at admission that, despite steep improvement during hospitalization, remains lower than that in patients with NFM at long-term follow-up, which holds true when only the viral forms are considered.

TL;DR: The safety and efficacy of the anti-IL6 tocilizumab (TCZ) in subjects with COVID-19 is reported in terms of overall survival and hospital discharge and Caution is warranted given the potential occurrence of adverse events.

TL;DR: A risk-based approach should be promoted in order to identify the most severe AM cases requiring appropriate bundles of care, including early recognition, transfer to tertiary centers, aggressive circulatory supports with inotropes and mechanical devices, histologic confirmation and eventual immunosuppressive therapy.

TL;DR: This poster presents a poster presented at the 2016 International Congress of the American College of Cardiac Surgeons (ICS) entitled “Cardiac Arrests and Surgeons’ Survival Skills: Foundations of Postoperative Care Quality and Management.”

TL;DR: A case of the successful recovery from severe COVID‐19 of a kidney‐transplanted patient treated with hydroxychloroquine, lopinavir/ritonavir, steroid, and tocilizumab is reported.